FDA Approved: ZTLIDO — Supplemental Application (Scilex Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZTLIDO (lidocaine topical system) by Scilex Pharmaceuticals, updating its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• ZTLIDO (LIDOCAINE)

Snippet

SUPPL AP for ZTLIDO (LIDOCAINE)